DURECT Corp (DRRX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DURECT Corp (DRRX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7173
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company’s product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and Relday, indicated for Schizophrenia and bipolar disorder. Durect’s major drug delivery technology platforms include Saber, Cloud, Oradur and Transdur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in California, the US.

DURECT Corp (DRRX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DURECT Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DURECT Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DURECT Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DURECT Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
DURECT Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DURECT Corp, Medical Equipment, Deal Details 10
Partnerships 10
Durect Enters into Licensing Agreement with Santen Pharma 10
Durect Enters Into Licensing Agreement with Virginia Commonwealth University Intellectual Property Foundation 11
Equity Offering 12
Durect Plans to Raise up to USD175 Million in Public Offering of Securities 12
Durect Files Registration Statement For Public Offering Of Securities For US$100.9 Million 13
Durect Files Registration Statement For Public Offering Of Common Stock For Up To US$25 Million 14
Durect Completes Public Offering Of Shares For US$11.5 Million 15
Durect Completes Public Offering Of Shares For US$13 Million 16
DURECT Corp – Key Competitors 17
DURECT Corp – Key Employees 18
DURECT Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Aug 01, 2018: DURECT announces second quarter 2018 financial results and provides corporate update 20
May 02, 2018: DURECT Reports First Quarter 2018 Financial Results 22
Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs 24
Nov 01, 2017: DURECT Announces Third Quarter 2017 Financial Results and Provides Corporate Update 26
Aug 08, 2017: DURECT Announces Second Quarter 2017 Financial Results and Provides Corporate Update 28
May 10, 2017: DURECT Announces First Quarter 2017 Financial Results and Provides Corporate Update 30
Mar 14, 2017: DURECT Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs 32
Corporate Communications 34
Oct 01, 2018: DURECT names Michael H. Arenberg as Chief Financial Officer 34
Oct 01, 2018: DURECT names Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer 35
Sep 20, 2017: DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
DURECT Corp, Medical Equipment, Key Facts, 2017 2
DURECT Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DURECT Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DURECT Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DURECT Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DURECT Corp, Deals By Market, 2012 to YTD 2018 8
DURECT Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Durect Enters into Licensing Agreement with Santen Pharma 10
Durect Enters Into Licensing Agreement with Virginia Commonwealth University Intellectual Property Foundation 11
Durect Plans to Raise up to USD175 Million in Public Offering of Securities 12
Durect Files Registration Statement For Public Offering Of Securities For US$100.9 Million 13
Durect Files Registration Statement For Public Offering Of Common Stock For Up To US$25 Million 14
Durect Completes Public Offering Of Shares For US$11.5 Million 15
Durect Completes Public Offering Of Shares For US$13 Million 16
DURECT Corp, Key Competitors 17
DURECT Corp, Key Employees 18

List of Figures
DURECT Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DURECT Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DURECT Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DURECT Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DURECT Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
DURECT Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DURECT Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[DURECT Corp (DRRX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LivaNova PLC (LIVN):企業の製品パイプライン分析2018
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depressio …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • U.P. Hotels Ltd.:企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petronas Dagangan Berhad (PETDAG):企業の財務・戦略的SWOT分析
    Petronas Dagangan Berhad (PETDAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Constellation Brands, Inc.:戦略・SWOT・企業財務分析
    Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ferguson Plc:企業のM&A・事業提携・投資動向
    Ferguson Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ferguson Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • SomaLogic Inc:企業の製品パイプライン分析2018
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • China Life Insurance Co Ltd:企業のM&A・事業提携・投資動向
    China Life Insurance Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Life Insurance Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • British Airways Plc:企業の戦略・SWOT・財務情報
    British Airways Plc - Strategy, SWOT and Corporate Finance Report Summary British Airways Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Western Energy Services Corp (WRG):企業の財務・戦略的SWOT分析
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • Trustpower Limited:企業の戦略的SWOT分析
    Trustpower Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • D.R. Horton Inc:戦略・SWOT・企業財務分析
    D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Uni-President China Holdings Ltd
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The Cleveland Clinic Foundation:企業の戦略的SWOT分析
    The Cleveland Clinic Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • US Oil Sands Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary US Oil Sands Inc (US Oil Sands), formerly Earth Energy Resources Inc, is an oil and gas company that explores and develops oil sand properties. The company has developed a proprietary process to oil sands development that uses a citrus based bio-solvent that naturally separates bitumen from …
  • Pakistan Water and Power Development Authority-エネルギー分野:企業M&A・提携分析
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • Kuwait Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Energy Plc (Kuwait Energy) is an independent oil and gas company that carries out exploration, appraisal, development and production of hydrocarbons. The company operates wide range of oil and gas assets in Middle East and North Africa (MENA) region. It has assets across Egypt, Yemen, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆